Skip to main content
. 2017 Nov 7;8(63):106258–106269. doi: 10.18632/oncotarget.22293

Table 3. Modification in antiplatelet therapy after platelet function testing.

Modification in Antiplatelet Therapy n = 204
Changed from aspirin to clopidogrel 126 (61.8%)
Changed from aspirin to cilostazol 23 (11.3%)
Increased aspirin 18 (8.8%)
Added clopidogrel to aspirin 37 (18.1%)